ventilation-perfusion ratio of about 1. However, all patients had in addition either a shunt or a mode of low V~/ Q units (Va/Q < 0.1), and four had both. Mean shunt was 5.4 percent (range 0-10.6 percent) and there was a mean of 9.3 percent of the cardiac output in the low ~A / Q mode (range 0-24.5 percent). On the other hand, there were virtually no regions with v a / Q ratios above the upper limit of normal. Oxygen breathing revealed no statistically significant increase in shunt over that found breathing room air, in spite of the presence of potentially unstable units of very low v a / Q ( < 0.1).
The distributions were therefore considerably different from those in both normal subjects (who did not have shunts or areas of such low Va/Q) and patients with chronic obstructive pulmonary disease (who also had no areas of such low '?do, generally much smaller shunts, and often areas of high VA/Q). The patterns are consistent with the concept that the interstitial disease process reduces compliance and hence both ventilation and ventilation-perfusion ratios in affected lung units.
We determined the role played by this VA/Q inequality in the cause of the hypoxemia by calculating the arterial Po, from the distributions. This was done by computing 0, content of end capillary blood in each V A / Q compartment, knowing venous and inspired Po, (each measured directly). Hemoglobin, P,, and acidbase status were taken into account. All of the hypoxemia at rest was explained adequately by the above abnormalities on the assumption that di&lsion equilibration for oxygen was complete in all gas exchange units. Thus at rest, there was no evidence for diffusion limitations as a factor contributing to hypoxemia. However, during exercise, the same computations yielded an arterial Po, from the distributions that averaged 10 mm Hg above the measured Po, values, suggesting that &ion limitation of oxygen was now contributing to the hypoxemia. This group of patients is the first in which diffusion limitation was seen under any conditions. However, since this difference made up only 19 percent of the total alveolar-arterial Po, difference, ventilationperfusion inequality remained the most important factor responsible for the low arterial Po,. 
P
ulmonary fibrosis constitutes a group of lung disorders of diverse etiology with variable prognosis which share in common the finding of a generalized increase in fibrous tissue on histologic examination. These diseases have been the subject of considerable research from the standpoint of histopathology and pulmonary physiology, but despite this, in most cases an etiology cannot be established and effective therapy is unavailable.
Biochemical approaches offer another avenue for exploring fibrotic lung disease, but because lung tissue offers considerable obstacles to biochemical investigation, relatively little is known concerning the biochemical events culminating in lung fibrosis. For example, no published data are available to indicate whether lung collagen content is, in fact, increased in the fibrotic lung diseases.
In order to understand the abnormal biochemical processes resulting in lung fibrosis, it is first necessary to delineate normal pathways of maintenance of lung structure. Physiologic and morphologic data suggest that the initial events in lung fibrosis are parenchymal and that airway abnormalities, although they do occur,l are later *From the Pulmonary Branch, National Heart and Lung Institute, Bethesda, Maryland.
manifestations of a primarily parenchymal process. Therefore, in seeking biochemical alterations in fibrotic lung disease, we have focused attention to the lung parenchyma (tissue devoid of major airways and vasculature) which represents 80 percent of total lung mass. 2 The major constituents of the lung parenchyma are listed in Table 1 .' Twenty percent of the parenchymal mass is extracellular, composed primarily of three connective tissue components, collagen, elastin and proteoglycans. Collagen is the most abundant, representing 60-70 percent of the parenchymal connective tissue. It is heterogeneous, composed of three genetically distinct macromolecules termed collagen type I, I11 and IV. Type I is also found in skin, bone, tendon and aorta; type I11 is found in skin, aorta and uterine leiomyoma; and type IV, the least characterized of the three, is the collagen component of basement membrane. Another collagen type (type 11), found only in cartilage-containing structures, is the major collagen of the tracheobronchial tree. It is not known where collagen types I and I11 are localized in the parenchyma. 3 Very little is known about lung parenchymal elastin, although crude estimates suggest it makes up 30-35 percent of the total parenchymal connective tissue.' It probably exists in two forms: a complex microfibrillar state and the more homogeneous amorphous form commonly seen on electron micrographs.
The proteoglycans are large proteins with many long complex carbohydrate side chains termed glycosaminoglycans. The proteoglycans are also heterogeneous. There are five types found in the adult lung parenchyma. Heparin and heparan sulfate are abundant (together they comprise 38 percent of the total glycosaminoglycans), although dermatan sulfate (28 percent), chondroitin Ssulfate (20 percent), hyaluronic acid (10 percent) and chondroitin 4-sulfate ( 4 percent) 
Yes yes Yes
"The data in this table are condensed from studies of large num are also present.'y5 Although the total glycosaminoglycans comprise less than 1 percent of the total parenchymal connective tissue, it is known from other organs and from in vitro studies that they exert powerful influences on the physical state of other connective tissue components. Thus, the glycosaminoglycans are potentially of crucial importance in the normal maintenance of parenchymal structure and mechanical properties. Eighty percent of the parenchymal mass is cellular. The vast majority of these cells are of four types: alveolar type I, alveolar type 11, endothelial and mesenchymal."
The macrophage, derived from the blood monocyte, is the fifth major cellular component of the normal adult alveolus.
M a i n t e~n c e of the Alveolus
Three major mechanisms of alveolar maintenance have been described: O o cell turnover (replication), connective tissue synthesis and connective tissue degrada-"The mesenchymal cell of the parenchyma has various names includin : interstitial cell, fibroblast and "fibroblast with lipid dro gts." Until better defined, the general term "mesenchymafl' is best used. ""The biochemical processes discussed here are as related to fibrotic disease; ie, surfactant synthesis and secretion by the type 11 cell is not considered as it has not, as yet, been related to the pathogenesis of these disorders.
~ber of investigators summarized in a recent review.2 tion. As cells age, they lose the ability to continue normal biochemical function. However, most of the cells of the alveolus can replicate (Table 1B) . Thus, the alveolus can maintain its cellular population with normally functioning cells and has the inherent ability to repair itself following injury. The relative number of each cell type present in the alveolus is potentially a critical determinant of interstitial composition (see below). From studies with cultured cells, it is known that the mesenchymal cell, at least one epithelial cell6 and probably the endothelial cell are all capable of connective tissue synthesis. For example, while a large fraction of the proteins secreted by the mesenchymal cell is collagen, much less of the secretory product of the epithelial cell is collagen. Thus, changing the cellular populations may result in changing the interstitial composition.
The presence of connective tissue in the interstitium is the result of a tightly cont~olled balance between synthesis and degradation. Although the latter is just begin-, ning to be quantitated, it is known that approximately 25% of the collagen that is synthesized by lung cells is destroyed within 4 hours.7 Preliminary studies suggest that this degradation occurs intracellularly or shortly after secretion and is probably unrelated to collagenase. The latter is an enzyme, specific for collagen, which is 
Biochemical Mechanisms in the Control of Alveolar Structure in Fibrotic Lung Disease
Although the histologic picture of fibrosis inherently suggests that the amount of lung collagen is increased in fibrotic disease, preliminary studies with biopsy specimens from patients with idiopathic disease suggest the situation is not that simple (Table 2 ) . Although patients with fibrotic disease have markedly increased cell densities, the collagen density is normal. Not only is collagen density normal, but the average rates of collagen synthesis per cell is not increased. The picture in experimental radiation-induced "fibrosis" is markedly different, with cell density decreased and collagen density increased. These initially surprising data underscore three important concepts of alveolar maintenance which must be taken into account in investigating fibrotic lung disease:
(1) Collagen accumulation in lung depends on a balance between synthesis and proteolysis. Potentially, there are at least four mechanisms by which collagen density could change. A change in the number of and/or type of alveolar cells involved in the synthesis of collagen, a change in the rate of synthesis per collagenproducing cell, or a change in the rate of collagen degradation would all alter the total lung collagen content and collagen density. In addition, a change in the amount of non-collagen lung mass would also affect collagen density. Average collagen density (currently the only reliable quantitative "monitor" of total collagen in a biopsy specimen) depends on all four factors which can change independently of each other, and possibly in ( 2 ) Lung collagen synthesis and degradation in fibrotic lung disease is potentially affected by a large number of lung and extra-lung biochemical mechanisms (Fig 1) . For example, the pulmonary macrophage has been implicated in stimulating collagen synthesis by fibroblasts,g producing collagenase and other proteolytic e n~y m e s ,~ as well as bringing proteolytic inhibitors to the lung.lO Similarly, mediators of the inflammatory and immune responses including polymorphonuclear leukocytes, lymphocytes, plasma cells, antibodies and complement may in certain circumstances affect either collagen synthesis, proteolysis or both. The role of serum factors, such as al-antitrypsin, a2-macroglobulin, hormones and environmental "fibrogenic" agents in determining collagen synthesis and proteolytic rates is as yet unexplored.
(3) Lung parenchyma is itself a complex with many "local" environments. Collagen is not evenly distributed through the parenchyma, but rather each local environment has a characteristic connective tissue content which may differ from each other in amount and/or type of collagen present and in the nature of associated connective tissue elements. Investigation of collagen content and synthesis in parenchyma results in an average of all these comparbnents. Changes in collagen in a small but crucially important compartment or destruction of collagen in one compartment with commensurate increases in collagen content in another compartment (such as destruction of alveolar and capillary basement membrane with concomitant increase in interstitial collagen) could be missed if the average content (parenchymal collagen content) was the only parameter investigated.
Thus, understanding of the biochemical basis of fibrotic lung disease will require knowledge of the balance of synthesis and proteolysis for the cell types capable of collagen synthesis, the rate of replication and death of collagen-synthesizing cells, how changes in synthesis and proteolysis are mediated by lung and extra-lung factors, and where in the parenchyma these events are occurring.
Simplified Models to Study F i b o t k Lung Disease
Because of the enormous complexity of this undertaking, we are seeking simplified models in which to study these events. Recent advances in lung cell separation, identification and cell culture techniques make tissue culture models attractive for several reasons. 2. Schematic representation of lung cell culture models of pulmonary fibrosis. The cells from biopsy specimens from patients with fibrotic disease are dispersed, separated (if desired) and grown in tissue culture. The biochemical response of these cells to lymphocytes, macrophages, fibrogenic agents, serum components alone or in combination can be quantitated with several parameters. In addition, drugs may be tested so as to determine, for each patient, the most e5ca-cious therapy.
LUNG CELL CULTURE MODELS OF PULMONARY FIBROSIS
First, both mesenchymal cells and lung epithelial cells can be maintained and passaged using standard tissue culture techniques.6.11 With the development of cultures of endothelial cells, representatives of the major cell types present in lung will be available for study. Second, techniques for measuring rate of cell division and cell death, as well as the rate of collagen synthesis and collagenase production have already been established. Therefore, it is possible to investigate the effects and mechanisms of cell-cell interactions, serum factors, fibrogenic agents and possible therapeutic agents on the synthesis and degradation of collagen on isolated types of lung cells, or lung cells obtained by biopsy from patients with fibrotic lung disease (Fig 2) . If the complex control of collagen synthesis and degradation can be understood, it may be possible to translate these in vitro models to the bedside. Although constant vigdance must be exercised to avoid drawing conclusions about in moo conditions solely from experiments performed in tissue culture, information obtained from these models should help direct investigation in several ways. Simplified tissue culture experiments may uncover effects which are obscured in in vivo experimentation. For instance, the finding that colchicine increases collagen degradation in culture12 will direct a search for this phenomenon in in vivo models of lung fibrosis. Similarly, the results of tissue culture experiments will facilitate in vivo experiments such as in the use of cell-specific antibodies produced against isolated cells to quantitate cell numbers in intact lung. However, as attractive as these methods may seem, it must always be kept in mind that only through correlation of biochemical data with pathologic and physiologic data will it be possible to obtain a complete understanding of the pathophysiology of 6-brotic lung disease. During the ensuing nine years, we have continued to refine our criteria for these two histologic diagnoses using as our working hypothesis the concept that DIP and UIP represent lesions which are distinct but related in that both are chronic diffuse interstitial pneumonias, produce similar symptoms and physiologic abnormalities, and may progress to identical nonspecific fibrosis and honeycombing. In order to judge the merits and clinical utility of this separation, we undertook this partly retrospective and partly prospective study with the following major goals: 1 ) to observe and compare prognosis and the probable corticosteroid response.
The pathologist who examined all slides before knowing any of the other findings graded the confidence of his diagnosis of UIP or DIP on a scale from 1-5. For this report, we selected only those 83 patients, 46 with UIP and 37 with DIP, in whom a histologic diagnosis could be made with a high degree of certainty (confidence 1-3 ) and for whom clinical evaluation, physiologic studies including at least one index of gas exchange, and adequate chest roentgenograms were obtained within one year of lung biopsy. By following a scheme of reading slides without clinical data, patients with collagenvascular disease were included while those with histologic evidence of pneumoconioses were excluded.
Clinical emination consisted of a modified Fletcher respiratory questionnaire. Also coded were results of physical examination, selected laboratory data and diagnoses. 
